Skip to content
FrontierPicks

Watching

CROX · Crocs

Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin

Wrong if: a daily close below $142

Business pivot Catalyst · Consumer brands & retail

Note written ·

How this view changed

  • · Rated Medium. Results, 29 October 2026: Crocs reported third-quarter 2026 adjusted EPS of $3.69 on $1,043 million revenue, above its own $3.20–$3.30 range, and raised full-year adjusted EPS guidance to $14.45–$14.65.

Price against the kill line

15.3% clear of its kill line on the 13 November 2026 close.

How to read this

The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

CROXCrocs
$142.00
$163.72
15.3%well clear

Three months against the kill line

CROX daily closes from 17 August 2026 to 13 November 2026, last $163.72, against its kill line: a daily close below $142.00. 17 August 2026: $129.9718 August 2026: $128.6619 August 2026: $125.7320 August 2026: $123.0921 August 2026: $122.1124 August 2026: $125.8425 August 2026: $122.8926 August 2026: $123.6427 August 2026: $121.6928 August 2026: $122.2331 August 2026: $120.381 September 2026: $115.282 September 2026: $115.793 September 2026: $116.014 September 2026: $117.538 September 2026: $114.359 September 2026: $111.0910 September 2026: $108.8311 September 2026: $112.4814 September 2026: $111.4915 September 2026: $111.4816 September 2026: $115.4017 September 2026: $123.0018 September 2026: $122.2421 September 2026: $123.6922 September 2026: $124.5823 September 2026: $124.6224 September 2026: $123.4425 September 2026: $126.1428 September 2026: $122.3629 September 2026: $122.6330 September 2026: $117.311 October 2026: $119.242 October 2026: $118.095 October 2026: $118.196 October 2026: $120.227 October 2026: $115.208 October 2026: $116.849 October 2026: $114.9812 October 2026: $116.9013 October 2026: $117.5314 October 2026: $117.5415 October 2026: $124.7716 October 2026: $123.1419 October 2026: $120.1820 October 2026: $121.3721 October 2026: $118.4922 October 2026: $120.9923 October 2026: $119.2326 October 2026: $118.8527 October 2026: $119.5028 October 2026: $119.6929 October 2026: $150.2630 October 2026: $150.522 November 2026: $153.133 November 2026: $153.614 November 2026: $159.845 November 2026: $152.936 November 2026: $151.869 November 2026: $160.2310 November 2026: $159.6611 November 2026: $159.9812 November 2026: $156.8813 November 2026: $163.72

Daily closes, to . Red: the kill line, a daily close below $142.00, on record since 10 November 2026. The shares are up 26.0% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close below $142, which would erase the post-earnings gap from the 29 October 2026 report. Fourth-quarter adjusted EPS below the $3.25 low end of guidance would also show the case failing.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

Key figures from the filings · Consumer Discretionary

Quarter to 30 September 2026, filed 29 October 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
1,043
Revenue, change on a year (%)
+4.6
Gross margin (%)
66.2
Operating margin (%)
28.0
Free cash flow, four quarters ($M)
754
Net cash, cash less debt ($M)
−1,126
Price to earnings (×)
11.3
Enterprise value to sales (×)
2.1
All filed numbers

What Crocs reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 1,043 +4.6 66.2 28.0
first filed 1,180 +2.6 59.4 24.2
first filed 922 −1.7 56.8 21.8
first filed 958 −3.2 54.7 15.3
first filed 996 −6.2 58.5 20.8
first filed 1,149 +3.4 61.7 −37.2
Income Quarter to 30 September 2026, filed 29 October 2026
Pre-tax income ($M) 277
Net income ($M) four quarters: 664 217
Diluted shares, change on a year (%) against the quarter to 30 September 2025 −11.2
Cash flow Four quarters to 30 September 2026, filed 29 October 2026
Operating cash flow ($M) 814
Capital spending ($M) 59.7
Free cash flow ($M) 754
Balance sheet At 30 September 2026, filed 29 October 2026
Cash and short-term investments ($M) 164
Debt ($M) non-current long-term debt 1,289
Net cash, cash less debt ($M) −1,126
Deferred revenue ($M) Not reported
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 355
Inventory ($M) 413
Shareholders' equity ($M) 1,345
Valuation At the 13 November 2026 close, filed figures to 29 October 2026
Market value ($M) 7,486
Enterprise value, market value plus net debt ($M) 8,612
Enterprise value to sales (×) 2.1
Enterprise value to operating income (×) 9.3
Price to earnings (×) 11.3
Price to book value (×) 5.6
Free-cash-flow yield (%) 10.1

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 9.9% of shares outstanding sold short, 4.4 days of average trading to cover, −8.7% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $613K $12.8M
12 monthsfrom $613K $23.0M

The thesis

Crocs, Inc. is more likely than not to beat the S&P 500 over the next three months. The third-quarter beat and a third full-year guidance raise, led by international sales and a return to growth at HEYDUDE, have reset earnings expectations higher. The fourth-quarter report, expected around mid-February 2027, settles whether full-year adjusted earnings per share (EPS) of $14.45–$14.65 holds.

Crocs reported third-quarter revenue of $1,043 million on 29 October 2026, up 4.6% from a year earlier. Adjusted EPS was $3.69 against $2.92 a year earlier. The company had guided the quarter to roughly flat revenue. HEYDUDE revenue rose 6.1% to $170 million, against guidance for a decline of 3% to flat. International Crocs Brand revenue rose 11.8% to $434 million.

The shares closed at $156.88 on 12 November 2026, 3.1% below the 52-week intraday high of $161.88 set on 4 November 2026. The three-month price change is 19.1%. The gain rests on the earnings reset, because Crocs Brand North America revenue still fell 2.1% to $438 million in the quarter.

Bullish and bearish views on Crocs, Inc.

The bull case on Crocs, Inc. (CROX), in brief: third quarter beat on every guided line. The bear case: North America shrank.

Bull case

  • Third quarter beat on every guided line. Adjusted EPS of $3.69 compared with a $3.30 consensus estimate, and revenue of $1,043 million with a $1.003 billion consensus estimate (Crocs Q3 2026 8-K; Benzinga, 29 October 2026).
  • Full-year guidance rose for the third time. Revenue growth is now about 3%, up from 1% to 2%. Adjusted diluted EPS guidance is $14.45–$14.65, up from $13.70–$14.00 (Crocs Q3 2026 8-K, 29 October 2026).
  • Fourth-quarter guide is above consensus. Crocs guided revenue up 7% to 9% and adjusted EPS of $3.25–$3.45, against a $3.10 consensus estimate (Benzinga, 29 October 2026).
  • HEYDUDE turned to growth. Third-quarter revenue grew 6.1%. Crocs now expects the brand to be about flat for 2026, up from a 2% to 4% decline, and to grow 10% to 12% in the fourth quarter (Crocs Q3 2026 8-K).
  • Underlying margin improved. Adjusted gross margin was 60.3%, up 180 basis points from a year earlier. The figure excludes a $64.1 million benefit from refunds of tariffs imposed under the International Emergency Economic Powers Act (Crocs Q3 2026 8-K).
  • Buybacks continue at scale. Crocs repurchased about 2.0 million shares for $250.0 million, an average of $123.32, in the third quarter. About $1.7 billion of authorization remained at 30 September 2026 (Crocs Q3 2026 8-K).
  • Analysts raised targets. Needham kept Buy with a $190 target (Benzinga, 29 October 2026). Barclays kept Overweight and raised its target to $178 from $139 (fiscal.ai, 30 October 2026).

Bear case

  • North America shrank. Crocs Brand North America revenue fell 2.1% to $438 million. The chief financial officer said a marketplace accounting change cut North American direct-to-consumer growth by about 270 basis points (Crocs Q3 2026 8-K; Modaes, 29 October 2026).
  • Insiders sold into the rally. SEC Form 4 filings show chief executive officer Andrew Rees sold 40,000 shares at an average $152.89 on 3 November 2026. Director Douglas Treff sold 10,714 shares at $159.21 on 4 November 2026 and 14,802 shares at an average $152.20 on 2 November 2026. Director Ronald Frasch sold 15,000 shares at $153.51 on 30 October 2026.
  • The shares sit above one target. UBS raised its target to $145 from $120 and kept a Neutral rating (fiscal.ai, 30 October 2026). The 12 November 2026 close of $156.88 is above it.
  • Part of the profit gain does not recur. GAAP (generally accepted accounting principles) gross margin was 66.2% because of the $64.1 million tariff refund, against 60.3% adjusted. Crocs expects a net non-GAAP benefit of about $40 million for the year, mainly from tariff refunds and cost reductions (Crocs Q3 2026 8-K).
  • Fourth-quarter margin is guided lower. Crocs guided adjusted operating margin of about 20.5% for the fourth quarter and above 22.5% for the full year (Crocs Q3 2026 8-K).
  • Borrowings remain large. Total borrowings were $1.29 billion against $163 million of cash on 30 September 2026 (Crocs Q3 2026 8-K).

Price setup

The shares closed at $156.88 on 12 November 2026, after closes of $160.23 on 9 November 2026, $159.66 on 10 November 2026 and $159.98 on 11 November 2026. The 52-week intraday high is $161.88, set on 4 November 2026. The 52-week closing low is $73.39, from 14 November 2025.

The 50-day average of adjusted closes is $126.77 and the 200-day average is $113.17, both as of 12 November 2026. The shares trade well above both. The close of $131.72 on 14 August 2026 is the reference for the 19.1% three-month change.

Investing.com's consensus page showed an average 12-month analyst target of $164.67 on 11 November 2026, with a range of $128 to $190. The close sits about 5% below that average, so the market has priced in most of the raised guidance and little of a further raise.

Catalysts ahead

  • 27 November 2026: US Black Friday; HEYDUDE holiday campaign with Riley Green running since 3 November 2026. Retailer commentary on holiday footwear demand bears on the fourth-quarter guide of revenue up 7% to 9%.
  • ~18 December 2026 (est.): Nike fiscal second-quarter report. Updates the sector read after Nike's 11% footwear decline in its fiscal first quarter.
  • ~15 February 2027 (est.): Crocs fourth-quarter and full-year 2026 report; date not yet announced. Tests the $3.25–$3.45 adjusted EPS guide and the $14.45–$14.65 full-year range.

What would change the view

A daily close below $142, which would erase the post-earnings gap from the 29 October 2026 report. Fourth-quarter adjusted EPS below the $3.25 low end of guidance would also show the case failing.

The risks this note tracks, each with what would confirm it:

  • North America keeps shrinking, and the marketplace accounting change plus weak wholesale hold back reported revenue. Confirmed by: Crocs Brand North America revenue below zero again in the fourth quarter, after the 2.1% decline to $438 million in the third quarter.
  • HEYDUDE's rebound fades and the guided 10% to 12% fourth-quarter growth is missed. Confirmed by: fourth-quarter HEYDUDE revenue growth below 10%, or a cut to the about-flat 2026 outlook.
  • Tariff-refund and cost-reduction gains that lifted 2026 profit do not repeat, leaving underlying margin under pressure. Confirmed by: fourth-quarter adjusted operating margin below the guided 20.5%, or adjusted gross margin below the 60.3% of the third quarter.
  • Insider selling continues into strength after the 30 October to 4 November 2026 sales by the chief executive and directors. Confirmed by: further SEC Form 4 filings showing open-market sales by executives or directors after 6 November 2026.
  • Buyback capacity narrows as borrowings of $1.29 billion meet $163 million of cash. Confirmed by: fourth-quarter repurchases well below the $250.0 million of the third quarter, or borrowings rising from the previous quarter.

What it trades with

Crocs trades with US consumer discretionary footwear and apparel. Nike's footwear decline of 11% in its fiscal first quarter (CNBC, 1 October 2026) did not stop the shares from rising after the Crocs report. The shares have moved on company results more than on sector direction.

On 29 October 2026, small caps rallied while the Nasdaq 100 fell after Alphabet dropped 11.8% (Benzinga), and Crocs rose that session. Wholesale customers and tariff policy are the shared exposures. The tariff refunds that lifted third-quarter GAAP margin tie reported profit to the outcome of US tariff rulings.

The evidence, claim by claim (8)
  1. Third-quarter 2026 revenue $1,043 million, up 4.6%; adjusted diluted EPS $3.69 against $2.92 a year earlier; Crocs Brand North America down 2.1% to $438 million, international up 11.8% to $434 million; HEYDUDE up 6.1% to $170 million. Crocs Q3 2026 earnings release (8-K) · as of
  2. Full-year 2026 guidance raised to revenue growth of about 3% and adjusted diluted EPS of $14.45–$14.65 from $13.70–$14.00; fourth-quarter guide revenue up 7% to 9% and adjusted EPS $3.25–$3.45. Crocs Q3 2026 earnings release (8-K) · as of
  3. Adjusted gross margin 60.3%, up 180 basis points; GAAP gross margin 66.2% includes a $64.1 million tariff-refund benefit excluded from adjusted results. Crocs Q3 2026 earnings release (8-K) · as of
  4. Third-quarter repurchases of about 2.0 million shares for $250.0 million (average $123.32); cash $163 million, total borrowings $1.29 billion, about $1.7 billion of authorization remaining. Crocs Q3 2026 earnings release (8-K) · as of
  5. Barclays maintained Overweight and raised its price target to $178 from $139; UBS raised its target to $145 from $120 with a Neutral rating. fiscal.ai analyst updates · as of
  6. Needham maintained Buy and raised its price target to $190. Benzinga · as of
  7. CEO Andrew Rees sold 40,000 shares at an average $152.89 on 3 November 2026; director Douglas Treff sold 10,714 shares at $159.21 on 4 November 2026. SEC Form 4 filings · as of
  8. Directors Thomas Smach and Beth Kaplan bought 680 and 885 shares in the open market at $111.49 and $112.12 on 15 September 2026. SEC Form 4 filings · as of

Sources

Related · shared themes

See also · stocks to watch

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X